DekaBank Deutsche Girozentrale - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,014
-19.1%
37,844
+8.1%
0.00%
-33.3%
Q2 2023$1,253
+47.9%
35,0000.0%0.00%
+50.0%
Q1 2023$847
-69.6%
35,000
-50.0%
0.00%
-71.4%
Q4 2022$2,786
-99.9%
70,0000.0%0.01%0.0%
Q3 2022$2,303,000
-15.5%
70,000
-12.6%
0.01%
-12.5%
Q2 2022$2,724,000
-8.2%
80,050
+23.1%
0.01%
+14.3%
Q1 2022$2,966,000
-10.7%
65,050
+30.0%
0.01%
-12.5%
Q4 2021$3,321,000
+25.2%
50,050
+14.1%
0.01%
+14.3%
Q3 2021$2,653,000
+10.1%
43,850
+46.9%
0.01%0.0%
Q2 2021$2,409,000
+27.5%
29,8500.0%0.01%
+16.7%
Q1 2021$1,890,000
-34.0%
29,850
-19.0%
0.01%
-45.5%
Q4 2020$2,865,000
+47.0%
36,850
-17.6%
0.01%
+22.2%
Q3 2020$1,949,000
+76.1%
44,700
+16.4%
0.01%
+50.0%
Q2 2019$1,107,000
-28.3%
38,400
-64.2%
0.01%
-33.3%
Q1 2019$1,544,000
+36.9%
107,200
+13.8%
0.01%
+28.6%
Q4 2018$1,128,000
-26.9%
94,200
-12.1%
0.01%
-22.2%
Q3 2018$1,544,000
+40.2%
107,200
+26.1%
0.01%
+28.6%
Q2 2018$1,101,00085,0000.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders